Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women.

Gut - 1 Sept 2012

Limsui David, Vierkant Robert A, Tillmans Lori S, Wang Alice H, Weisenberger Daniel J, Laird Peter W, Lynch Charles F, Anderson Kristin E, French Amy J, Haile Robert W, Harnack Lisa J, Potter John D, Slager Susan L, Smyrk Thomas C, Thibodeau Stephen N, Cerhan James R, Limburg Paul J

Abstract excerpt

BACKGROUND: Postmenopausal hormone (PMH) therapy may reduce colorectal cancer (CRC) risk, but existing data are inconclusive. OBJECTIVES: To evaluate associations between PMH therapy and incident CRC, overall and by molecularly defined subtypes, in the population-based Iowa Women's Health Study of older women. METHODS: Exposure data were collected from Iowa Women's Health Study participants (55-69 years) at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Estrogen Replacement Therapy
Share to Iowa

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Microsatellite Instability

Share to Postmenopause

Share to Proportional Hazards Models

Share to Proto-Oncogene Proteins B-raf

Share to Registries

Share to Surveys and Questionnaires

Source

Open in PubMed Open full text

Identifiers

PMID: 22027477
DOI: 10.1136/gutjnl-2011-300719
PMCID: PMC3584677

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women.PMID 22027477Read ↗

Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways.Semantic proximity Read ↗

Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women.Semantic proximity Read ↗

Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.Semantic proximity Read ↗

Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.Semantic proximity Read ↗

Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older women.Semantic proximity Read ↗

Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.Semantic proximity Read ↗

Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study.Semantic proximity Read ↗

Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.Semantic proximity Read ↗

Association Between Smoking and Molecular Subtypes of Colorectal Cancer.Semantic proximity Read ↗

Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk.Semantic proximity Read ↗

Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.Semantic proximity Read ↗

Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.